It is very uncertain whether anticoagulant agent changes major bleeding (hospital records/every 6 weeks) compared with placebo (very low certainty).
The review found no eligible studies for this question.
Anticoagulant agent may leads to lower adverse events (hospital records/every 6 weeks) compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Lipid‐lowering agent showed no clear difference in ipsilateral major or disabling stroke (only reported for two… compared with placebo or no treatment (low certainty).
Lipid‐lowering agent showed no clear difference in stroke‐related mortality (only reported for one study: CT scan, MRI… compared with placebo or no treatment (low certainty).
The review found no eligible studies for this question.
Antiplatelet agent showed no clear difference in ipsilateral major or disabling stroke (CT scan or MRI) compared with placebo (low certainty).
The review found no eligible studies for this question.
Lipid‐lowering agent showed no clear difference in adverse events (only reported for two studies: one study used CT… compared with placebo or no treatment (low certainty).
The review found no eligible studies for this question.
Antiplatelet agent showed no clear difference in stroke‐related mortality (CT scan or MRI) compared with placebo (low certainty).
It is very uncertain whether antiplatelet agent changes major bleeding (not reported) compared with placebo (very low certainty).
Antiplatelet agent showed no clear difference in progression of carotid stenosis (DUS/every 6 months) compared with placebo (low certainty).
Antiplatelet agent showed no clear difference in adverse events (not reported) compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Thrombo‐aspiration alone showed no clear difference in functional independence at 3 months (mRS 0 to 2) (primary outcome) compared with stent‐retrieval thrombectomy alone (high certainty).